General Information of Drug (ID: DMHP9BL)

Drug Name
Etelcalcetide Drug Info
Synonyms Velcalcetide; Parsabiv; UNII-60ME133FJB; 1262780-97-1; 60ME133FJB; etelcalcetide HCl; Etelcalcetide [USAN:INN]; Etelcalcetide (USAN/INN); Etelcalcetide Hydrochloride(AMG-416)
Indication
Disease Entry ICD 11 Status REF
Secondary hyperparathyroidism 5A51.1 Approved [1]
Myelodysplastic syndrome 2A37 Phase 3 [2]
Cross-matching ID
PubChem CID
71511839
ChEBI ID
CHEBI:134700
CAS Number
CAS 1262780-97-1
TTD Drug ID
DMHP9BL
ACDINA Drug ID
D01061

Molecule(s) Related to This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Extracellular calcium-sensing receptor (CASR) TTBUYHA CASR_HUMAN Modulator [3]

The Expression Level of Molecule(s) in Normal Tissue of Major ADME-Related Organs

Molecule Molecule Type Gene Name Liver Colon Kidney Small Intestine
Extracellular calcium-sensing receptor (CASR) DTT CASR 4.966 4.892 5.342 5.37
Molecule Expression Atlas in Normal Tissue of Major ADME-related organs

The Expression Level of Molecule(s) between Disease Section and Healthy Individual Tissue

The Studied Disease Secondary hyperparathyroidism
ICD Disease Classification 5A51.1
Molecule Name Molecule Type Gene Name p-value Fold-Change Z-score
Extracellular calcium-sensing receptor (CASR) DTT CASR 4.50E-02 0.23 4.1
Molecular Expression Atlas between Disease Section and Healthy Individual Tissue

References

1 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2018
2 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800031284)
3 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services.